FEMOSTON-CONTI 0.5/2.5 Milligram Film Coated Tablet Írország - angol - HPRA (Health Products Regulatory Authority)

femoston-conti 0.5/2.5 milligram film coated tablet

bgp products ltd - estradiol, dydrogesterone - film coated tablet - 0.5/2.5 milligram - progestogens and estrogens, fixed combinations

Femoston-conti 0.5mg/2.5mg tablets Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

femoston-conti 0.5mg/2.5mg tablets

viatris uk healthcare ltd - estradiol; dydrogesterone - oral tablet - 500microgram ; 2.5mg

Femoston-conti 1mg/5mg film-coated Tablets Málta - angol - Malta Medicines Authority

femoston-conti 1mg/5mg film-coated tablets

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - film-coated tablet - dydrogesterone 5 mg estradiol 1 mg - sex hormones and modulators of the genital system

FEMOSTON 1/10 1 mg, 10 m Milligram Film Coated Tablet Írország - angol - HPRA (Health Products Regulatory Authority)

femoston 1/10 1 mg, 10 m milligram film coated tablet

abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 1 mg, 10 m milligram

FEMOSTON 2 mg, 10 m Milligram Film Coated Tablet Írország - angol - HPRA (Health Products Regulatory Authority)

femoston 2 mg, 10 m milligram film coated tablet

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 2 mg, 10 m milligram - progestogens and estrogens, sequential preparations - sequential hormone replacement therapy - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 6 months since the last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

FEMUREST-CONTI 1/5 Milligram Film Coated Tablet Írország - angol - HPRA (Health Products Regulatory Authority)

femurest-conti 1/5 milligram film coated tablet

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 1/5 milligram - progestogens and estrogens, fixed combinations

FEMOSTON-CONTI tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

femoston-conti tablet blister pack

viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hypromellose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.

FEMOSTON 2/10 2 mg, 10 m Milligram Film Coated Tablet Írország - angol - HPRA (Health Products Regulatory Authority)

femoston 2/10 2 mg, 10 m milligram film coated tablet

abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 2 mg, 10 m milligram

Femoston conti 0.5mg/2.5mg film-coated tablets Málta - angol - Malta Medicines Authority

femoston conti 0.5mg/2.5mg film-coated tablets

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - film-coated tablet - dydrogesterone 2.5 mg estradiol 0.5 mg - sex hormones and modulators of the genital system

Femoston Conti 0.5mg2.5mg Film Coated Tablet Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

femoston conti 0.5mg2.5mg film coated tablet

abbott laboratories (m) sdn. bhd. - estradiol hemihydrate; dydrogesterone -